Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Laboratorios Farmacéuticos ROVI, S.A. announces strategic expansion and growth plans in a press release coinciding with its Ordinary General Shareholders’ Meeting. The company’s latest forecasts and business information can be accessed via their website. However, the company cautions that these forward-looking statements contain risks and uncertainties, and actual results may vary.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.